Enamine will resume operations on limited basis, CEO says, as Russian forces withdraw from Ukrainian capital
As Russian forces withdraw from several parts of Ukraine, including the capital Kyiv, the firm Enamine says it’s getting back to work.
The Kyiv-based company, which several biopharmas rely on to help produce the key ingredients that go into their experimental drugs, put out a statement Thursday titled simply “Resuming Work.” CEO Andrey Tolmachov explains that as the situation in Kyiv slowly returned to “normal” over the last two weeks, Enamine feels as though now is the time to restart operations on a limited basis.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.